Poxvirus-vectors have been widely used in vaccine development for several important human and animal diseases; some of these vaccines have been licensed and used extensively. Swinepox virus (SPV) is well suited to develop recombinant vaccines because of its large packaging capacity for recombinant DNA, its host range specifi city, and its ability to induce appropriate immune responses.
CITATION STYLE
Fan, H. J., & Lin, H. X. (2016). Recombinant swinepox virus for veterinary vaccine development. In Methods in Molecular Biology (Vol. 1349, pp. 163–175). Humana Press Inc. https://doi.org/10.1007/978-1-4939-3008-1_11
Mendeley helps you to discover research relevant for your work.